Global Respiratory Diagnostics Market Trends, Applications, Analysis, Growth, and Forecast: 2018 to 2027
Global Respiratory Diagnostics Market Overview:
“The global Respiratory Diagnostics Market size is expected to be worth around US$ xx Billion by 2021 from US$ X.xx million in 2031, growing at a CAGR of X.x% during the forecast period 2021 to 2031.”
Respiratory diseases represent a major cause of morbidity and mortality among all age groups worldwide. Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide and the numbers are growing. Five respiratory conditions accounting for a great burden to society are chronic obstructive pulmonary disease, asthma, acute respiratory infections, tuberculosis, and lung cancer. According to Forum of International Respiratory Societies (FIRS), each year 4 million people die from chronic respiratory disease.
Key market driver of global respiratory diagnostics is, increasing prevalence of respiratory diseases. In addition, technological advancement in respiratory diagnostic testing, growth in geriatric population with respiratory disorders, increase in the demand for respiratory devices in private hospitals and clinics, high consumption of tobacco and smoking, urbanization, growing pollution levels, sedentary lifestyle are the factors boosting the growth of global respiratory diagnostics market. However, high price associated diagnosis and testing, strict regulatory requirements and reimbursement concerns hinder the growth of market.
Respiratory diseases are an enormous challenge to life, health and productive human activity. The government are taking various initiative to spread the public awareness and control of the environment regarding prevention and treatment of respiratory diseases. The key players are focusing on new product launches, clinical trials, research and development, through agreements, joint ventures, partnerships, acquisitions, with other players.
The market in North America is estimated to dominate the respiratory diagnostics, rising prevalence of respiratory diseases such as COPD, asthma etc. The market in Asia Pacific is the emerging market for respiratory diagnostics due to improving health care infrastructure and increasing patient awareness regarding availability of diagnostic procedures. The emerging economies of Asia Pacific region, such as China and India are offering huge revenue generation opportunities for the key players in the market.
Global Respiratory Diagnostics Market Segmentation:
Segmentation on the basis of product and service:
- Instruments & Devices
- Assays & Reagents
- Software & Services
Segmentation on the basis of test type:
- Mechanical tests
- Imaging tests
- Traditional diagnostic tests
- Molecular diagnostic tests
Segmentation on the basis of disease:
- Chronic obstructive pulmonary disease
- Lung cancer
- Other diseases (including, bronchitis, respiratory infection, pulmonary fibrosis etc.)
Segmentation on the basis of end user:
- Other end users (including blood banks, point-of-care testing, patient self-testing etc.)
Segmentation on the basis of region:
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Attribute Report Details Market Size Ask For Market Size Growth Rate Ask For Growth Rate Key Companies Ask For Companies Report Coverage Revenue analysis, Competitive landscape, Key company analysis, Market Trends, Key segments, Distribution Channel, Market Dynamics, COVID-19 Impact Analysis and more… Historical Data Period 2015-2020 Base Year 2022 Forecast Period 2022-2031 Region Scope North America, Europe, Asia-Pacific, South America, Middle East & Africa Country Scope United States, Canada and Mexico, Germany, France, UK, Russia and Italy, China, Japan, Korea, India and Southeast Asia, Brazil, Argentina, Colombia etc.Saudi Arabia, UAE, Egypt, Nigeria and South Africa Revenue in US$ Mn
- Becton, Dickinson and Company
- Koninklijke Philips N.V
- MGC Diagnostics Corporation
- Medtronic, Inc.
- CAREstream Medical Ltd.
- ResMed Inc.
- Thermo Fisher Scientific Inc.
- GE Healthcare Limited
- Abbott Diagnostics Inc.
- Fisher & Paykel Healthcare, Inc.
Request for TOC
Why Choose Us
- 360 Degree Approach
- Growth Consulting
- 24/7 Research Support
- Comprehensive-Level of Customization
- Comprehensive-Level of Customization
- Competitive Intelligence
- Single-Country/ Region Intelligence
- Post-Sale Service Assistance
- Access to Lead Analysts
- Available in PDF, Excel, Word/ PPT
Request for Customization
Don't just take our word. We are trusted by these great companies!